Clinical Trials
12
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
Effects of a Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment
Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial
Sample Size for Multivariate Time-to-event Data
Clinical Trial Preference Study
Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy
Surgical Site Infection Outcomes in Natural Orifice Intracorporeal Anastomosis and Extraction (NICE) Procedure - The NICE Trial
Effect of the Postoperative Trendelenburg Position on Chronic Subdural Hematoma Recurrence
Effects of Cognitive Training on Chemotherapy-Induced Cognitive Impairment in Colon Cancer Patients Undergoing Treatment(Chemobrain) in Oncology Patients With Colon Cancer Undergoing Active Treatment
PREconception Folic Acid Clinical Efficacy (PREFACE) Trial
Factors Affecting Selection of Leadless Pacemaker and Atrioventricular Synchronous Pacing Status
Integrating Family Caregiver Support Into Cancer Clinical Trials
Knowledge and Perception of Clinical Trial Participation in Breast Cancer Patients in Egypt